HCM
WST icon

Hillman Capital Management’s West Pharmaceutical WST Stock Holding History

Hillman Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.23M Hold
8,906
– – 1.55% 34
2025
Q4 		$2.45M Sell
8,906
-1,367
-13% -$374K 1.54% 36
2025
Q3 		$2.69M Buy
+10,273
New +$2.5M 1.57% 36

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Hillman Capital Management's WST Position: Q1 2026 in Review

Hillman Capital Management held its West Pharmaceutical (WST) position steady in Q1 2026 at 8,906 shares worth $2.23M. The position accounts for 1.55% of the portfolio, ranked #34.

Hillman Capital Management first reported a position in WST in Q3 2025 and has held it in 3 quarters since. The position peaked at $2.69M in Q3 2025. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Hillman Capital Management held 8,906 shares of West Pharmaceutical worth $2.23M as of Q1 2026.
  • Hillman Capital Management left its West Pharmaceutical share count unchanged in Q1 2026.
  • West Pharmaceutical made up 1.55% of Hillman Capital Management's portfolio in Q1 2026, its #34 holding.
  • Hillman Capital Management first reported a position in West Pharmaceutical in Q3 2025 and has held it in 3 quarters since.
  • Hillman Capital Management's West Pharmaceutical position peaked at $2.69M in Q3 2025.
  • 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Hillman Capital Management's 13F filing for Q1 2026, filed 15 May 2026.